Abstract:Background Tuberculosis (TB) remains a major public health concern worldwide. Previous studies have demonstrated that IL-17 plays an important role in initial immune response and is involved in both immune-mediated protection and pathology following infection with Mycobacterium tuberculosis (MTB). However, the alterations and regulation of plasma IL-17 level during TB treatment remain unclear. Moreover, the cell type responsible for the production of IL-17 in TB patients requires further study. Methods A total of 20 acid-fast bacilli smear-positive (AFB-positive) pulmonary TB patients and 20 age- and gender-matched healthy volunteers were included in our study. Blood samples were collected in heparinized tubes at the time of diagnosis (AFB-positive group) and 3 weeks after the initiation of therapy, when the sputum smear conversion (AFB-negative group) occurred, followed by symptomatic improvement. IL-17 levels and IL-17-producing cells in PBMCs were detected. Lymphocyte populations in the peripheral blood between the AFB-positive and AFB-negative groups were compared by flow-cytometry. A549 cells, a cell line of alveolar epithelial cells, were applied to determine the extent of the pathological damage mediated by IL-17 following MTB infection. Recombinant human IL-10 was used to investigate the regulation of IL-17 expression after sputum smear conversion in AFB-positive pulmonary TB patients. Results Plasma IL-17 level were elevated in patients with sputum AFB-positive pulmonary TB, but substantially decreased after TB treatment and smear conversion. Our data indicate that NKT-like cells might be the main source of IL-17, in addition to conventional T cells in AFB-positive pulmonary TB patients. The secretion of IL-17 may be suppressed by regulatory T (Treg) cells and IL-10 during TB treatment. Moreover, the IL-17 levels were positively correlated to both the C-reactive protein and erythrocyte sedimentation rate. Therefore, IL-17 was capable of alveolar epithelial cell damage following MTB infection. Conclusion The increase in the frequency of Treg cells and IL-10 levels was associated with a decrease in IL-17 in patients receiving TB treatment. Thus, IL-10 and Tregs may function to inhibit immune-mediated pathology in TB patients.

Innate lymphoid cells exhibited IL-17-expressing phenotype in active tuberculosis disease

Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

Characterization of cytokine profile to distinguish latent tuberculosis from active tuberculosis and healthy controls.

ILC2s Induce Adaptive Th2-type Immunity in Different Stages of Tuberculosis Through the Notch-GATA3 Pathway.

Mycobacterium Tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12.

The Expressions and Roles of Different Forms of IL-22 in Mycobacterium Tuberculosis Infection.

B cell infiltration is associated with the increased IL-17 and IL-22 expression in the lungs of patients with tuberculosis

A subset of CD1c + dendritic cells is increased in patients with tuberculosis and promotes Th17 cell polarization.

Increased Frequency of ILT2-expressing CD56dimCD16+ NK Cells Correlates with Disease Severity of Pulmonary Tuberculosis

Characterization of Membrane-Bound IL-22+ T Cell Subsets in HIV-1 Patients Coinfected with Mycobacterium Tuberculosis.

Increased Frequencies of T Helper Type 17 Cells in Tuberculous Pleural Effusion.

Elevation in the counts of IL-35-producing B cells infiltrating into lung tissue in mycobacterial infection is associated with the downregulation of Th1/Th17 and upregulation of Foxp3+Treg

Single-cell transcriptome sequencing reveals altered peripheral blood immune cells in patients with severe tuberculosis

The immune characterization of interferon-β responses in tuberculosis patients

In vitro stimulation with nontuberculous mycobacteria induced a stronger cytokine response in leukocytes isolated from individuals with latent tuberculosis compared to those isolated from active tuberculosis or cystic fibrosis patients

ILC2s induce Treg but not Th2-type immunity through IL-33/ST2 pathway in pulmonary tuberculosis

Peripheral imbalance of Th1/Th17 immune responses in a Chinese population with active tuberculosis

Differentiation, Distribution and Γδ T Cell-Driven Regulation of IL-22-producing T Cells in Tuberculosis (45.21)

Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells Suppress Mycobacterium Tuberculosis Immunity in Patients with Active Disease

Depletion of IL-22 During Culture Enhanced Antigen-Driven IFN-γ Production by CD4+T Cells from Patients with Active TB

Role of invariant nature killer T cell in dysbiosis of gut microbiota among Mycobacterium tuberculosis infected patients